Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: A randomized controlled trial (E-LIFT trial)
Kuchay MS et al. Diabetes Care 2018: dc180165. doi: 10.2337/dc18-0165
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.